Engineering cells to make better mRNA.

Developing a cost-efficient and scalable platform for the production of high-quality mRNA to enable the next generation of mRNA therapeutics and vaccines.

The future of mRNA technology is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible Biotechnologies is on a journey to solve this problem by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA on demand.